Matthew Dankner

This study identifies 59 gene expression programs in RCC that reveal subtype identity and metastatic trajectories, including a metastatic signature linked to poor clinical outcomes.

This paper analyzes the clinical, genomic, and transcriptomic features of BRAF mutant cancers across multiple tumor types and identifies demographic and molecular differences between BRAF mutation classes.